177 related articles for article (PubMed ID: 22410715)
41. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
[TBL] [Abstract][Full Text] [Related]
42. [Retrospective analysis of 47 cases with hilar cholangiocarcinoma using T-staging system].
Peng CH; Zhao ZM; Peng SY; Liu YB; Wu YL; Fang HQ; Jiang XC
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(1):56-9. PubMed ID: 15774176
[TBL] [Abstract][Full Text] [Related]
43. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
44. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
[TBL] [Abstract][Full Text] [Related]
45. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
[TBL] [Abstract][Full Text] [Related]
46. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF
BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639
[TBL] [Abstract][Full Text] [Related]
47. Different characteristics and prognostic impact of deep-vein thrombosis / pulmonary embolism and intraabdominal venous thrombosis in colorectal cancer patients.
Choi S; Lee KW; Bang SM; Kim S; Lee JO; Kim YJ; Kim JH; Park YS; Kim DW; Kang SB; Kim JS; Oh D; Lee JS
Thromb Haemost; 2011 Dec; 106(6):1084-94. PubMed ID: 22072215
[TBL] [Abstract][Full Text] [Related]
48. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
[TBL] [Abstract][Full Text] [Related]
49. D-dimer before chemotherapy might predict venous thromboembolism.
Arpaia G; Carpenedo M; Verga M; Mastrogiacomo O; Fagnani D; Lanfredini M; Milani M; Cimminiello C
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):170-5. PubMed ID: 19276795
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
Khorana AA; Francis CW; Culakova E; Lyman GH
Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
[TBL] [Abstract][Full Text] [Related]
51. Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findings.
Mandalà M; Barni S; Floriani I; Isa L; Fornarini G; Marangolo M; Mosconi S; Corsi D; Rulli E; Frontini L; Cortesi E; Zaniboni A; Aglietta M; Labianca R
Eur J Cancer; 2009 Jan; 45(1):65-73. PubMed ID: 19068274
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.
Connolly GC; Menapace L; Safadjou S; Francis CW; Khorana AA
Clin Lung Cancer; 2013 Nov; 14(6):713-8. PubMed ID: 23891560
[TBL] [Abstract][Full Text] [Related]
53. Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival.
Diaz ES; Walts AE; Karlan BY; Walsh CS
Gynecol Oncol; 2013 Dec; 131(3):541-5. PubMed ID: 24041880
[TBL] [Abstract][Full Text] [Related]
54. Predictors for thromboembolism in patients with cholangiocarcinoma.
Pfrepper C; Knödler M; Schorling RM; Seehofer D; Petros S; Lordick F
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2415-2426. PubMed ID: 34499224
[TBL] [Abstract][Full Text] [Related]
55. Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population.
Park LC; Woo SY; Kim S; Jeon H; Ko YH; Kim SJ; Kim WS
Thromb Res; 2012 Sep; 130(3):e6-12. PubMed ID: 22507288
[TBL] [Abstract][Full Text] [Related]
56. [Incidence of venous thromboembolism in 700 patients with acute tuberculosis].
Shitrit D; Fox L; Preiss R; Raz M; Mtvitzuk A
Harefuah; 2012 Apr; 151(4):208-10, 254. PubMed ID: 22616147
[TBL] [Abstract][Full Text] [Related]
57. [Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism].
Liu FF; Zhai ZG; Yang YH; Wang J; Wang C
Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1860-3. PubMed ID: 24124734
[TBL] [Abstract][Full Text] [Related]
58. The incidence of venous thromboembolism in patients with overt hyperthyroidism: a retrospective multicentre cohort study.
Kootte RS; Stuijver DJ; Dekkers OM; van Zaane B; Fliers E; Cannegieter SC; Gerdes VE
Thromb Haemost; 2012 Mar; 107(3):417-22. PubMed ID: 22234657
[TBL] [Abstract][Full Text] [Related]
59. Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival.
Abu Saadeh F; Norris L; O'Toole S; Gleeson N
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):214-8. PubMed ID: 23830352
[TBL] [Abstract][Full Text] [Related]
60. [Efficacy of neoadjuvant chemoradiation therapy for clinical Stage II cholangiocarcinoma as a preoperative diagnosis].
Nakagawa K; Katayose Y; Unno M
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1945-7. PubMed ID: 23267938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
